This topic contains a solution. Click here to go to the answer

Author Question: L.H.'s lesions and abilities were consistent with ____. a. differences between spatial and visual ... (Read 104 times)

geoffrey

  • Hero Member
  • *****
  • Posts: 880
L.H.'s lesions and abilities were consistent with ____.
 
  a. differences between spatial and visual imagery
 b. the relative importance of spatial imagery
 c. the relative importance of visual imagery
 d. the functional equivalence of visual and spatial imagery

Question 2

L.H. was able to see and was able to draw, but he was unable to _____.
 
  a. mentally scan images
 b. link verbal labels to what he had drawn
  c. mentally rotate images
 d. state locations



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jaymee143

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

a

Answer to Question 2

b




geoffrey

  • Member
  • Posts: 880
Reply 2 on: Jun 20, 2018
YES! Correct, THANKS for helping me on my review


ryansturges

  • Member
  • Posts: 338
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

To prove that stomach ulcers were caused by bacteria and not by stress, a researcher consumed an entire laboratory beaker full of bacterial culture. After this, he did indeed develop stomach ulcers, and won the Nobel Prize for his discovery.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library